β-amyloïde (1-40), met HFIP behandeld (TFA)

β-Amyloid (1-40), HFIP-treated is a β-Amyloid (1-40) treated with HFIP. β-Amyloid (1-40) is a primary protein in plaques found in the brains of patients with Alzheimer's disease[1].

12352209

Amyloid-β

Neuronal Signaling

Neuroscience-Neurodegeneration

Neurological Disease

99.89

O=C([C@@H](N)CC(O)=O)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(NCC(NCC(N[C@H](C(N[C@H](C(O)=O)C(C)C)=O)C(C)C)=O)=O)=O)C(C)C)=O)CCSC)=O)CC(C)C)=O)=O)[C@H](CC)C)=O)[C@H](CC)C)=O)C)=O)=O)CCCCN)=O)CC(N)=O)=O)CO)=O)=O)C(C)C)=O)CC(O)=O)=O)CCC(O)=O)=O)C)=O)CC1=CC=CC=C1)=O)CC2=CC=CC=C2)=O)C(C)C)=O)CC(C)C)=O)CCCCN)=O)CCC(N)=O)=O)CC3=CNC=N3)=O)CC4=CNC=N4)=O)C(C)C)=O)CCC(O)=O)=O)CC5=CC=C(O)C=C5)=O)=O)CO)=O)CC(O)=O)=O)CC6=CNC=N6)=O)CCCNC(N)=N)=O)CC7=CC=CC=C7)=O)CCC(O)=O)=O)C.OC(C(F)(F)F)=O.[x]

C194H295N53O58S.xC2HF3O2

4329.80 (free base)

[1]Shoji M, et al. Cerebrospinal fluid Abeta40 and Abeta42: natural course and clinical usefulness. Front Biosci. 2002 Apr 1;7:d997-1006.|[2]Nitta A, et al. β-Amyloid protein-induced Alzheimer's disease animal model[J]. Neuroscience letters, 1994, 170 (1) : 63-66.

Blue Ice

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

http://file.medchemexpress.com/batch_PDF/HY-P0265C/

Peptides

No Development Reported